396
Views
9
CrossRef citations to date
0
Altmetric
Commentary

Bringing greater transparency to “black box” warnings

&
Pages 448-451 | Received 13 Apr 2011, Accepted 30 May 2011, Published online: 04 Oct 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Emad Eldin Munsour, Ahmed Awaisu, Mohamed Azmi Ahmad Hassali, Hamda Ali & Zeinab Dabbous. (2019) A comparative evaluation of written medicine information of antidiabetic medicines from Qatar, Australia and Europe. Cogent Medicine 6:1.
Read now

Articles from other publishers (8)

Lucy T. Perry, Alice Bhasale, Alice Fabbri, Joel Lexchin, Lorri Puil, Maisah Joarder & Barbara Mintzes. (2020) A descriptive analysis of medicines safety advisories issued by national medicines regulators in Australia, Canada, the United Kingdom and the United States ‐ 2007 to 2016. Pharmacoepidemiology and Drug Safety 29:9, pages 1054-1063.
Crossref
Karina Jayaputra & Shunsuke Ono. (2017) Differences between the United States and Japan in labels of oncological drugs. Pharmacoepidemiology and Drug Safety 26:2, pages 143-151.
Crossref
Jennifer M. Polinski, Aaron S. Kesselheim, John D. Seeger, John G. Connolly, Niteesh K. Choudhry & William H. Shrank. (2015) A cross-national comparison of 17 countries' insulin glargine drug labels. Pharmacoepidemiology and Drug Safety 24:2, pages 159-165.
Crossref
Suvimol Niyomnaitham, Andrew Page, Adam La Caze, Karen Whitfield & Alesha J Smith. (2014) Utilisation trends of rosiglitazone and pioglitazone in Australia before and after safety warnings. BMC Health Services Research 14:1.
Crossref
Barbara Mintzes. (2013) Medication safety: opening up the black box. BMJ Quality & Safety 22:9, pages 702-704.
Crossref
Aaron S Kesselheim, Jessica M Franklin, Jerry Avorn & Jon D Duke. (2013) Speaking the same language? International variations in the safety information accompanying top-selling prescription drugs. BMJ Quality & Safety 22:9, pages 727-734.
Crossref
Dennis J. Mazur. (2013) Informed Consent in the Twenty‐First Century: What It Is, What It Isn't, and Future Challenges in Informed Consent and Shared Decision Making. Sociology Compass 7:9, pages 762-774.
Crossref
Rumiko Shimazawa & Masayuki Ikeda. (2013) Safety information in drug labeling: a comparison of the USA, the UK, and Japan. Pharmacoepidemiology and Drug Safety 22:3, pages 306-318.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.